Curative Biotechnology, Inc. (CUBT)
OTCMKTS
· Delayed Price · Currency is USD
0.0101
-0.0008 (-7.34%)
Apr 28, 2025, 2:25 PM EDT
Curative Biotechnology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
10.56M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |
Curative Biotechnology News
- 4 months ago - Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor - GlobeNewsWire
- 1 year ago - Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors - GlobeNewsWire
- 1 year ago - Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors - GlobeNewsWire
- 2 years ago - Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions - GlobeNewsWire
- 2 years ago - Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation - GlobeNewsWire
- 2 years ago - Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study - GlobeNewsWire
- 2 years ago - Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange - GlobeNewsWire
- 3 years ago - Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors - GlobeNewsWire